Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Clinical Interventions in Aging
|
May 8, 2013
Onset, longevity, and patient satisfaction with incobotulinumtoxinA for the treatment of glabellar frown lines: a single-arm, prospective clinical study
Welf Prager, Eva K Bee, Isabel Havermann, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 31, 2014
IncobotulinumtoxinA for the treatment of platysmal bands: a single-arm, prospective proof-of-concept clinical study
Welf Prager, Eva K Bee, Isabel Havermann, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 8, 2010
Comparison of two botulinum toxin type A preparations for treating crow's feet: a split-face, double-blind, proof-of-concept study
Welf Prager, Esther Wissmüller, Bianca Kollhorst, et al.
Clinical, Cosmetic and Investigational Dermatology
|
April 3, 2015
IncobotulinumtoxinA use in aesthetic indications in daily practice: a European multicenter, noninterventional, retrospective study
Tatjana Pavicic, Welf Prager, Markus Klöppel, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
September 12, 2015
Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results From a Randomized, Double-Blind, Placebo-Controlled, Phase III Study
Martina Kerscher, Berthold Rzany, Welf Prager, et al.
Clinical, Cosmetic and Investigational Dermatology
|
September 24, 2016
Hyaluronic acid fillers with cohesive polydensified matrix for soft-tissue augmentation and rejuvenation: a literature review
Adri D Prasetyo, Welf Prager, Mark G Rubin, et al.
Journal of Drugs in Dermatology : JDD
|
June 3, 2020
Safety, Tolerability, and Efficacy of Repeat-Dose Injections of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results from a Prospective, Open-Label, Phase III Study
Tanja Fischer, Gerhard Sattler, Welf Prager, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
July 5, 2012
A prospective, split-face, randomized, comparative study of safety and 12-month longevity of three formulations of hyaluronic acid dermal filler for treatment of nasolabial folds
Welf Prager, Esther Wissmueller, Isabel Havermann, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
August 21, 2021
Safety of Cohesive Polydensified Matrix Cross-Linked Hyaluronic Acid Volumizing Gel in Temporal Hollows and Cheeks: A Prospective, Open-Label, Postmarket Study
Tatjana Pavicic, Gerhard Sattler, Welf Prager, et al.
Clinical, Cosmetic and Investigational Dermatology
|
September 5, 2020
Safety and Performance of Etermis 3 and 4 in Wrinkles/Folds Treatment and Facial Volume Enhancement: A Prospective, Evaluator-Blinded, Open-Label Study
Gerhard Sattler, Martina Kerscher, Ernst Magnus Noah, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Clinical Interventions in Aging
|
May 8, 2013
Onset, longevity, and patient satisfaction with incobotulinumtoxinA for the treatment of glabellar frown lines: a single-arm, prospective clinical study
Welf Prager, Eva K Bee, Isabel Havermann, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 31, 2014
IncobotulinumtoxinA for the treatment of platysmal bands: a single-arm, prospective proof-of-concept clinical study
Welf Prager, Eva K Bee, Isabel Havermann, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 8, 2010
Comparison of two botulinum toxin type A preparations for treating crow's feet: a split-face, double-blind, proof-of-concept study
Welf Prager, Esther Wissmüller, Bianca Kollhorst, et al.
Clinical, Cosmetic and Investigational Dermatology
|
April 3, 2015
IncobotulinumtoxinA use in aesthetic indications in daily practice: a European multicenter, noninterventional, retrospective study
Tatjana Pavicic, Welf Prager, Markus Klöppel, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
September 12, 2015
Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results From a Randomized, Double-Blind, Placebo-Controlled, Phase III Study
Martina Kerscher, Berthold Rzany, Welf Prager, et al.
Clinical, Cosmetic and Investigational Dermatology
|
September 24, 2016
Hyaluronic acid fillers with cohesive polydensified matrix for soft-tissue augmentation and rejuvenation: a literature review
Adri D Prasetyo, Welf Prager, Mark G Rubin, et al.
Journal of Drugs in Dermatology : JDD
|
June 3, 2020
Safety, Tolerability, and Efficacy of Repeat-Dose Injections of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results from a Prospective, Open-Label, Phase III Study
Tanja Fischer, Gerhard Sattler, Welf Prager, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
July 5, 2012
A prospective, split-face, randomized, comparative study of safety and 12-month longevity of three formulations of hyaluronic acid dermal filler for treatment of nasolabial folds
Welf Prager, Esther Wissmueller, Isabel Havermann, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
August 21, 2021
Safety of Cohesive Polydensified Matrix Cross-Linked Hyaluronic Acid Volumizing Gel in Temporal Hollows and Cheeks: A Prospective, Open-Label, Postmarket Study
Tatjana Pavicic, Gerhard Sattler, Welf Prager, et al.
Clinical, Cosmetic and Investigational Dermatology
|
September 5, 2020
Safety and Performance of Etermis 3 and 4 in Wrinkles/Folds Treatment and Facial Volume Enhancement: A Prospective, Evaluator-Blinded, Open-Label Study
Gerhard Sattler, Martina Kerscher, Ernst Magnus Noah, et al.
Page
of 4